Stem Cell Exosome Treatment for Frontotemporal Dementia
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This trial tests whether exosomes (tiny particles from stem cells) can help slow or improve symptoms of frontotemporal dementia, a disease affecting thinking and behavior. You would receive the treatment and be monitored to see if it helps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with frontotemporal dementia (behavioral, language, or speech variant) with brain imaging showing shrinkage in the front or side of the brain
- Age 30–80 years old
- Have a study partner (family member or caregiver) who visits at least 3 hours daily and can help manage study medication
- Mild to moderate memory and thinking changes (specific test scores required)
- Any brain or behavior medications must be stable for at least 30 days before starting
- Not pregnant, planning pregnancy, or breastfeeding during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if vortioxetine, an antidepressant, can improve mood symptoms (like depression or anxiety) and thinking abilities in people with frontotemporal dementia (FTD). It also includes healthy volunteers for comparison.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
This study tests whether tiny particles called exosomes derived from neural stem cells can help slow memory loss and thinking problems in people with Alzheimer's disease that started before age 65. The treatment is given through the nose and aims to reduce harmful proteins in the brain.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
This study tests an experimental treatment for people with a specific type of frontotemporal dementia (the semantic variant). The goal is to see if it is safe and helps with symptoms. You may be able to join if you have mild to moderate symptoms and have had a recent test showing no Alzheimer's disease.
This study tests a new treatment made from stem cells (called secretome) to see if it can help people with moderate dementia. It's for patients who are generally stable and have a caregiver to support them.
Hear when a new Frontotemporal Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.